By analyzing key variables such as hormone receptor status, molecular subtypes, tumor grade, and chemotherapy regimens, we seek to provide insights into recurrence patterns and prognostic factors, ultimately contributing to more effective, individualized treatment strategies for breast cancer patients. This evidence concerns the gene NR4A1 and neoplasm.